Skip to main content
. 2021 Dec 9;11:705634. doi: 10.3389/fonc.2021.705634

Figure 1.

Figure 1

miRNA and anti-cancer drug combinations can potentially synergistically affect tumor growth through their respective activities and potential synergistic effects on the tumor cells and the tumor microenvironment. With miRNAs mediating cell proliferation, drug resistance or angiogenesis, exogenous upregulation or inhibition of miRNAs in combination with anti-proliferative, cytotoxic or anti-angiogenic drugs represents a rationally designed and promising research development.